About us
Unveiling Our Identity,
Vision and Values
Shreepad Shree Vallabh, SSV Phytopharmaceuticals develops patented NDDS technologies, such as Advanced Liposomal and Aquasol Technology, which enhance bioavailability and efficacy. With these, vitamins, minerals, and phytoactives are transformed into highly absorbable, water-soluble formats.
SUSTAINABILITY
SAFETY
EFFICACY
INNOVATION
MISSION
- Enhanced Bioavailability & Efficacy to maximize health benefits.
- Global Accessibility ensuring wellness solutions reach everyone.
- Research-Backed Products designed for proven effectiveness and safety.
- Revolutionizing Nutraceuticals with advanced delivery systems and innovation.
VISION
- Global Nutraceutical Innovation with Patented, Proven Technologies
- Science-Driven Solutions delivering health, wellness, and longevity.
- Enhanced Bioavailability & Efficacy through advanced delivery systems.
- Trusted Quality & Global Reach ensuring safe, effective, and accessible products.
Our Timeline
2019
Foundation
Shreepad Shree Vallabh Phytopharmaceuticals was founded, marking the beginning of our journey in innovation-driven nutraceuticals.
Shreepad Shree Vallabh Phytopharmaceuticals was founded, marking the beginning of our journey in innovation-driven nutraceuticals.
2020
Innovation During Covid-19
Developed and patented the breakthrough formulation CURVIC, conducted clinical trials, and published preclinical data in reputed journals like Nature. The formulation showed effectiveness in Covid-19 patients, receiving global appreciation for Dr. Yogesh Dound and wide acceptance in the scientific community.
Developed and patented the breakthrough formulation CURVIC, conducted clinical trials, and published preclinical data in reputed journals like Nature. The formulation showed effectiveness in Covid-19 patients, receiving global appreciation for Dr. Yogesh Dound and wide acceptance in the scientific community.
2021
Resuming Core Development
Post-pandemic, the focus shifted back to advancing technology development and research activities.
Post-pandemic, the focus shifted back to advancing technology development and research activities.
2022–2023
Technology Advancements
Major focus was on the development and validation of Aquasol and Liposomal Technologies, strengthening our innovation pipeline.
Major focus was on the development and validation of Aquasol and Liposomal Technologies, strengthening our innovation pipeline.
2023
Commercial Breakthrough
Initiated commercial production and successfully executed our first liposomal commercial shipment, establishing our market presence.
Initiated commercial production and successfully executed our first liposomal commercial shipment, establishing our market presence.
2025
Exponential Growth
Achieved a major milestone with commercial shipments of Creatine Monohydrate and Coenzyme Q10. Additionally, our Veg/Vegan Vitamin D3 is ready to enter the global market.
Achieved a major milestone with commercial shipments of Creatine Monohydrate and Coenzyme Q10. Additionally, our Veg/Vegan Vitamin D3 is ready to enter the global market.
Our Global Footprint
Trusted by partners and consumers across continents
Subscribe to our newsletter
Stay up-to-date on the latest Shreepad Shree Vallabh,
SSV Phytopharmaceuticals news and other Platform Technology information.